Wyndgate Technologies(R) Expands Its Donor Solution in the Hospital Market With University of North Carolina
April 12 2006 - 10:00AM
PR Newswire (US)
DENVER, April 12 /PRNewswire-FirstCall/ -- Wyndgate
Technologies(R), a division of Global Med Technologies(R), Inc.,
(OTC:GLOB) (BULLETIN BOARD: GLOB) announced today that it has
signed an agreement with the University of North Carolina Hospitals
(UNC Hospitals) to provide its SafeTrace(R) donor management
system. Terms of the agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
Located in Chapel Hill, UNC Hospitals is already a user of
Wyndgate's transfusion management software solution, SafeTrace
Tx(R)*. With its purchase of SafeTrace, it is now Wyndgate's newest
Vein-to-Vein(R) client. Once the donor management system is
installed, it will interface seamlessly with the medical center's
SafeTrace Tx system to allow complete blood donation tracking from
collection through laboratory testing and final transfusion.
SafeTrace will also assist the hospital with pre-collection
capabilities such as donor recruitment and scheduling. Laura
McClannan, Assistant Administrative Director for Transfusion
Medicine at UNC Hospitals, stated, "Our staff selected Wyndgate's
SafeTrace donor management system for its ability to offer
comprehensive safety features and to fully integrate our donor and
transfusion services. SafeTrace can help UNC Hospitals grow our
donor program and alleviate concerns about the capability of our
operations to keep up with that growth. We believe that the future
of Wyndgate and UNC Hospitals mirror each other -- both positive.
Considering our experience with SafeTrace Tx, adding Wyndgate's
SafeTrace solution was the wise choice." Wm. Scott Dustin, Vice
President of Sales and Marketing for Wyndgate Technologies, said,
"We are very pleased to announce this agreement with such a
prestigious medical center as UNC Hospitals. UNC Hospitals saw the
value of the implementation experience Wyndgate provided during the
installation of our transfusion solution, SafeTrace Tx. UNC
Hospitals' installation of Wyndgate's donor management software
clearly demonstrates Wyndgate's commitment to the growing hospital
blood donation center market." About the University of North
Carolina Health Care System The UNC Health Care System is a
not-for-profit integrated health care system owned by the state of
North Carolina. UNC Health Care is made up of UNC Hospitals --
including N.C. Memorial Hospital, N.C. Children's Hospital, N.C.
Women's Hospital, N.C. Neurosciences Hospital and the N.C. Jaycee
Burn Center -- and is associated with the University of North
Carolina at Chapel Hill School of Medicine. This network allows the
system to move the results of biomedical research from medical
school laboratories to patient care settings. For more information,
visit their website at http://www.unchealthcare.org/. About Global
Med Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx(R) advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000; or Investor Relations, Paul Short, President
of Investment Strategies, LLC, +1-304-523-3252, for Global Med
Technologies, Inc. Web site: http://www.unchealthcare.org/ Web
site: http://www.globalmedtech.com/ http://www.wyndgate.com/
Copyright